SARS-CoV-2
Translingual edit
Etymology edit
Proper noun edit
- (virology) Severe acute respiratory syndrome-related coronavirus 2; a virus which causes COVID-19 coronavirus disease, first discovered in 2019, in an outbreak that started in Wuhan, Hubei, China.
- For quotations using this term, see Citations:SARS-CoV-2.
Synonyms edit
(virus):
Hypernyms edit
- (virus): Riboviria - realm; Orthornavirae - kingdom; Pisuviricota - phylum; Pisoniviricetes - class; Nidovirales - order; Cornidovirineae - suborder; Coronaviridae - family; Orthocoronavirinae - subfamily; Betacoronavirus - genus; Sarbecovirus - subgenus (per NCBI)
Hyponyms edit
(virus): The number of variants and their names shows a dynamic growth. See e.g. Variant_of_concern
Coordinate terms edit
(virus):
closest known relatives to SARS-CoV-2
(viral components)
Related terms edit
(virus):
References edit
- ^ BioRxviv, "Severe acute respiratory syndrome-related coronavirus – The species and its viruses, a statement of the Coronavirus Study Group", Alexander E. Gorbalenya, 11 February 2020, International Committee on Taxonomy of Viruses, Coronavirus Study Group
Further reading edit
SARS-CoV-2 on Wikipedia.Wikipedia 
SARS-CoV-2 on Wikispecies.Wikispecies 
SARS-CoV-2 on Wikimedia Commons.Wikimedia Commons - SARS-CoV-2 at National Center for Biotechnology Information
English edit
2.jpg)
Pronunciation edit
- (Received Pronunciation) IPA(key): /ˈsɑːz ˈkəʊviː ˈtuː/
- (General American) IPA(key): /ˈsɑɹz ˈkoʊvi ˈtu/
Proper noun edit
- (virology) SARS-CoV-2; SARS-related coronavirus 2
- 2020 April, Lu, Xiaoxia, Liqiong Zhang, Hui Du, Jingjing Zhang, Yuan Y. Li, Jingyu Qu, Wenxin Zhang et al., “SARS-CoV-2 infection in children”, in New England Journal of Medicine, volume 382, number 17, :
- As of March 10, 2020, the 2019 novel coronavirus (SARS-CoV-2) has been responsible for more than 110,000 infections and 4000 deaths worldwide, but data regarding the epidemiologic characteristics and clinical features of infected children are limited.
- 2021 June, Krause, Philip R., Thomas R. Fleming, Ira M. Longini, Richard Peto, Sylvie Briand, David L. Heymann, Valerie Beral, Matthew D. Snape, Helen Rees, Alba-Maria Ropero, Ran D. Balicer, Jakob P. Cramer, et al., “SARS-CoV-2 Variants and Vaccines”, in New England Journal of Medicine, :
- In addition to continuing to track the emergence of new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there are four major priorities for the global response to variants of concern.